Arkea Bio
Charlestown, US · Founded 2021 · 4 known investors
Find your way into Arkea Bio
Sign up to see every warm intro you have to Arkea Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arkea Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
ArkeaBio develops a methane-reducing vaccine for cattle that lowers agricultural emissions without disrupting farm operations, targeting livestock producers to enable low-carbon dairy and beef production. The vaccine activates a natural immune response in ruminants and integrates seamlessly with existing farming practices.
Founders & leadership


Board
Investors · 4
How we know: a partner's Signal profile · funding news · arkeabio.com · Not right? Tell us
How we know: NYA Ventures's portfolio page · Not right? Tell us
How we know: Rabo Corporate Venturing's portfolio page · Not right? Tell us
How we know: agfundernews.com · Not right? Tell us
Funding
SEC filings, press & company announcements$48.5M disclosed across 3 of 7 rounds · 2022–2026
- Undisclosed amountSeries A1Sep 2025
AgriZeroNZ (lead), Breakthrough Energy Ventures (lead)
Source ↗ - Undisclosed amountSeries A+Sep 2025
AgriZeroNZ (lead), Breakthrough Energy Ventures (lead)
Source ↗ - $26.5MSeries AMay 2024 · 2 sourcesSource ↗
- Undisclosed amountSeedDec 2022Source ↗
▶$15MraisedOct 2026 · 2 investors · Other TechnologyRule 506(b)
- Frank WootenExecutive Officer, Director
- Zachariah SerberExecutive Officer
- Chris RivestDirector
- Wayne McNeeDirector
- Offering amount
- $33M
- Amount sold
- $15M
- First sale
- Sep 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7MraisedOct 2025 · 2 investors · Other TechnologyRule 506(b)
- Frank WootenExecutive Officer, Director
- Wayne McNeeDirector
- Chris RivestExecutive Officer, Director
- Zachariah SerberExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $7M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶Undisclosed amountofferedDec 2023 · Other TechnologyRule 506(b)
- Ginja SilvaExecutive Officer
- Chris RivestExecutive Officer, Director
- Matthew DunnExecutive Officer
- Zachariah SerberDirector
- Colin SouthExecutive Officer, Director
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Arkea Bio do?
- ArkeaBio develops a methane-reducing vaccine for cattle that lowers agricultural emissions without disrupting farm operations, targeting livestock producers to enable low-carbon dairy and beef production. The vaccine activates a natural immune response in ruminants and integrates seamlessly with existing farming practices.
- Who are Arkea Bio's investors?
- Arkea Bio's investors include Breakthrough Energy Ventures, NYA Ventures, Rabo Corporate Venturing, AgriZeroNZ.
- How much funding has Arkea Bio raised?
- Arkea Bio has disclosed $48.5M raised across 3 of its 7 known rounds.
- Where is Arkea Bio headquartered?
- Arkea Bio is headquartered in Charlestown, US.


